Nalin Payakachat

基本信息

浏览量：39

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 176 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Qualité De Vie Liée À La Santé (hrqol) Et Symptômes Chez Les Patients De L’essai LIBRETTO-431 Atteints De Cancer Bronchique Non À Petites Cellules (CBNPC) Avancé Avec Fusion Du Gène RET

P. Tomasini, C. Zhou, S. Novello, P. Garrido, C. Dooms, J. Alatorre-Alexander, N. Reinmuth,A.M. Gilligan,N. Payakachat,K. Cocks,G. Worthy, K. Goto, M. Petrillo

Revue des Maladies Respiratoires Actualitésno. 1 (2025): 242

引用0浏览0引用

Meaningful Change Threshold Estimation for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Psychometric Analysis from a Phase 3 Trial (LIBRETTO-431)

Nathan Clarke, Gill Worthy,Nalin Payakachat,Adrienne M. Gilligan,Kim Cocks

Quality of Life Research（2025）

引用0浏览0WOS引用

ID: 342895 Assessment of Psychosocial Factors and Success of Neuromodulation Trials for Treatment of Persistent Pain

Johnathan Goree,Nalin Payakachat, Lauren Byers, Gregory Smith, Jarna Shah,Kimberly Stephens

Neuromodulation Technology at the Neural Interface（2024）

引用0浏览0引用

Time to Deterioration of Patient-Reported Outcome Endpoints in Cancer Clinical Trials: Targeted Literature Review and Best Practice Recommendations

Kim Cocks,Bellinda L. King-Kallimanis,Joel Sims, Gill Worthy, Julia Stein,Lara Ayala–Nunes, Monika Achra,Zhanglin Lin Cui,Nalin Payakachat

Journal of patient-reported outcomesno. 1 (2024): 150-150

引用0浏览0WOS引用

Assessing Tolerability with the Functional Assessment of Cancer Therapy Item GP5: Psychometric Evidence from LIBRETTO-531, a Phase 3 Trial of Selpercatinib in Medullary Thyroid Cancer

Antoine Regnault, Laurine Bunod,Angely Loubert,Marcia S. Brose,Lisa M. Hess,Patricia Maeda, Yan Lin, Rebecca M. Speck,Adrienne M. Gilligan,Nalin Payakachat

Journal of Patient-Reported Outcomesno. 1 (2024): 1-10

引用0浏览0WOS引用

Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force

Edward Henry,Hareth Al-Janabi,Werner Brouwer,John Cullinan,Lidia Engel,Susan Griffin,Claire Hulme,Pritaporn Kingkaew,Andrew Lloyd,Nalin Payakachat,Becky Pennington,Luz María Peña-Longobardo,Lisa A. Prosser,Koonal Shah,Wendy J. Ungar,Thomas Wilkinson,Eve Wittenberg

PHARMACOECONOMICSno. 3 (2024): 343-362

引用9浏览0WOS引用

Patient-reported Outcomes of First-Line Selpercatinib Versus Chemotherapy with or Without Pembrolizumab in RET Fusion-Positive Advanced Non-Small Cell Lung Cancer: Interim Analysis of LIBRETTO-431

Koichi Goto,Silvia Novello,Pilar Garrido,Christophe Dooms,Jorge Alatorre-Alexander,Niels Reinmuth,Adrienne Gilligan,Nalin Payakachat,Aimee Bence-Lin,Kim Cocks,Gill Worthy,Caicun Zhou

ONCOLOGY RESEARCH AND TREATMENT (2024): 246-246

引用0浏览0引用

Mixed-methods Research to Support the Use of New Lymphoma-Specific Patient-Reported Symptom Measures Derived from the EORTC Item Library

Jessica T. Markowitz,Flora Mazerolle,Teya Lovell,Lisa M. Hess,Paolo B. Abada,Antoine Regnault,Nalin Payakachat

Journal of Patient-Reported Outcomes（2024）

引用0浏览0WOS引用

Time to Worsening of Patient Reported Outcomes. Recommendations for Best Practice in Oncology

Joel Sims, Mike Greenwood, Bellinda King-Kallimanis, Gill Worthy, Julia Stein,Lara Ayala-Nunes, Monika Achra, Zhanglin Cui,Kim Cocks,Nalin Payakachat

QUALITY OF LIFE RESEARCH (2024): S58-S58

引用0浏览0引用

PCR254 Evidence to Support the Use of the Functional Assessment of Cancer Therapy – General Item GP5 (FACT-GP5) to Assess Comparative Tolerability Endpoint: Results from the LIBRETTO-531 Trial

A Regnault, L Bunod,A Loubert,A Gilligan,P Maeda, Y Lin,L Hess,N Payakachat

Value in Healthno. 6 (2024): S343-S344

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 176 篇作者统计合作学者相似作者